Skip to content
10-Q

Quarterly Report

CervoMed Inc. CRVO

0001437749-26-017236

← back to feed
Filed
May 15, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 6, 2026 9.26M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$8.02M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$3.89M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $7.94M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $8.24M
Stockholders Equity Q1 2026 · Mar 31, 2026 $10.62M
Stockholders Equity Q1 2026 · Dec 31, 2025 $18.22M
Stockholders Equity Q1 2026 · Mar 31, 2025 $34.63M
Stockholders Equity Q1 2026 · Dec 31, 2024 $39.2M
Total Liabilities Q1 2026 · Mar 31, 2026 $4.5M
Total Liabilities Q1 2026 · Dec 31, 2025 $4.66M
Current Assets Q1 2026 · Mar 31, 2026 $15.11M
Current Assets Q1 2026 · Dec 31, 2025 $22.88M
Total Assets Q1 2026 · Mar 31, 2026 $15.11M
Total Assets Q1 2026 · Dec 31, 2025 $22.88M
Eps Basic Q1 2026 · Mar 31, 2026 −$0.86
Eps Basic Q1 2026 · Mar 31, 2025 −$0.56
Sga Expense Q1 2026 · Mar 31, 2026 $2.98M
Sga Expense Q1 2026 · Mar 31, 2025 $2.38M
Rd Expense Q1 2026 · Mar 31, 2026 $5.14M
Rd Expense Q1 2026 · Mar 31, 2025 $4.84M
Net Income Q1 2026 · Mar 31, 2026 −$7.96M
Net Income Q1 2026 · Mar 31, 2025 −$4.89M
Operating Income Q1 2026 · Mar 31, 2026 −$8.11M
Operating Income Q1 2026 · Mar 31, 2025 −$5.3M
Revenue Q1 2026 · Mar 31, 2026 $0
Revenue Q1 2026 · Mar 31, 2025 $1.92M